Stay updated on AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision v3.4.2 was added to the history, and the previous revision v3.4.1 was removed.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision history was updated with a new entry (v3.4.1) and removal of the previous revision (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision v3.3.4 was added and the previous revision v3.3.3 was removed from the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page history now includes Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check93 days agoChange DetectedAdded a new revision (v3.3.2) and removed an older revision (v3.2.0) from the Study Record Versions list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedThe banner about government funding and operations has been removed from the page, and the study information remains unchanged.SummaryDifference0.7%

Stay in the know with updates to AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page.